Delivery Order 75N91023D00010-75N91024F00002

Award Date 9/25/24
Potential Completion Date 9/24/27
Potential Value $1.5M
Awardee
Mriglobal
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $790,714 delivery order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute). The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage forms. This delivery order is issued under the Drug Formulation and Manufacturing Contracts 2019 multiple-award indefinite-delivery,...
This federal contract award, with an ID of 75N91023D00010|75N91024F00001, was issued by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract, which is not set aside, has a ceiling value of $1,866,116.00 and a completion date of September 17, 2026. The scope of the contract includes the production of a drug substance, conversion of the drug substance to a drug product, filling the drug product into applicators for clinical...
This is a $25,543,276.37 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the not-for-profit research organization Mriglobal (doing business as Midwest Research Institute). The contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations. Mriglobal is a highly experienced federal contractor, holding several significant...
This is a delivery order awarded to Mriglobal, doing business as Midwest Research Institute, under a $79,617 cost-plus-fixed-fee contract for contract management support activities. The order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS). Mriglobal is a 501(c)(3) not-for-profit research organization that provides scientific research, testing, training, and product development...
This is a $4,415,116.56 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, to provide shelf life evaluation of investigational dosage forms. The contract does not have a small business set-aside designation. Mriglobal is an independent, not-for-profit research organization that conducts over $110 million in research annually for federal and commercial...
This is a delivery order awarded under a $3,500,000 indefinite-delivery, indefinite-quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract is for the Diagnostics Pre-Clinical Services Program and is a firm fixed-price arrangement. The prime contractor is Mriglobal, a 501(c)(3) not-for-profit research organization that provides scientific research, testing, training, and product...
This is a $500,000.00 definitive contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The contract is for IGF::OT::IGF FOR OTHER FUNCTIONS with a completion date of September 24, 2019. It is a firm fixed-price contract and was not set aside for any specific business type. Mriglobal conducts over $110 million in research annually for...
This is a $88,303 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Mriglobal, a 501(c)(3) not-for-profit research organization doing business as Midwest Research Institute. The contract is for "Genomic Makers Bioinformatics" services and has an ultimate completion date of September 29, 2023. Mriglobal is a long-standing provider of scientific research, testing, and product development services to federal agencies including...
This is a firm fixed-price delivery order contract awarded by the Washington Headquarters Service, a defense agency, to Mriglobal, a 501(c)(3) not-for-profit research organization doing business as Midwest Research Institute. The contract, valued at $96,840.00, is for special studies work. Mriglobal is a prime contractor that frequently partners with universities, research institutes, and small businesses to provide scientific research, testing, training, and product development services to...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute. The contract, valued at $100,000.00, is a Delivery Order under the NIAID Animal Models of Infectious Diseases 2010-2017 IDIQ contract. It is for the provision of animal models of infectious diseases. The contract does not have a set-aside designation. Mriglobal is a...
  • 75N91023D00010
    Indefinite Delivery Contract
  • 75N91023D00010-75N91024F00002
    Delivery Order

This is a delivery order federal contract awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $1,524,929.00 contract is for the manufacture of plasmid DNA drug substance and drug product. The period of performance runs through September 24, 2027.

Mriglobal has been awarded multiple significant federal contracts and grants to support public health and national security programs. For this contract, Mriglobal has subcontracted a portion of the work to Genscript Probio USA Inc., a small disadvantaged business, for the production of a primary cell bank and plasmid DNA drug substance. Mriglobal also holds several multi-million dollar indefinite delivery/indefinite quantity (IDIQ) contracts with agencies like the National Institute of Allergy and Infectious Diseases, the National Center for Advancing Translational Sciences, and the Office of the Assistant Secretary for Preparedness and Response, allowing for rapid procurement of its specialized scientific and technical services.

Generated 3/21/25, 9:45 AM